Exact Sciences had some rough times, but its stock rebounded and is now at record highs. In addition, he makes $18,716,500 as Chairman of the Board, President und Chief Executive Officer at EXACT Sciences. The estimated Net Worth of Kevin T Conroy is at least $111 Million dollars as of 27 February 2020.
Our management team, led by CEO and President Kevin Conroy, guides Exact Science's efforts to provide the best colorectal cancer screening tests, treatment guidance, and monitoring. In 2009 Kevin Conroy was appointed CEO of Exact Sciences Corporation (NASDAQ:EXAS).This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization.
Exact Sciences net worth as of … When Kevin took over in April 2009, Exact Sciences had a handful … Kevin T. Conroy is Nominee Independent Director of the Company.
How Does Kevin Conroy’s Compensation Compare With Similar Sized Companies? See our latest analysis for Exact Sciences . Interactive chart of historical net worth (market cap) for Exact Sciences (EXAS) over the last 10 years.
Our data indicates that Exact Sciences Corporation is worth US$13b, and total annual CEO compensation was reported as US$7.0m for the year to December 2018.
CEO Kevin Conroy believes the company, which is expanding its footprint in …
Kevin has made over 52 trades of the EXACT Sciences stock since 2011, according to the Form 4 filled with the SEC. Mr. Conroy owns over 20,575 units of EXACT Sciences stock worth over $90,755,554 and over the last 11 years he sold EXAS stock worth over $1,268,593.
How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Most recently he exercised 20,575 units of EXAS stock worth …